Steven Morrison1, Gang Han2, Faith Elenwa2, John T Vetto3, Graham Fowler1, Stanley P Leong4, Mohammed Kashani-Sabet4, Barbara Pockaj5, Heidi E Kosiorek5, Jonathan S Zager6,7, Jane L Messina6, Nicola Mozzillo8, Schlomo Schneebaum9, Dale Han1. 1. Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA. 2. Department of Epidemiology and Biostatistics, Texas A&M University, College Station, TX, USA. 3. Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA. vettoj@ohsu.edu. 4. California Pacific Medical Center and Research Institute, San Francisco, CA, USA. 5. Mayo Clinic, Phoenix, AZ, USA. 6. Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA. 7. Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA. 8. Istituto Tumori Napoli Fondazione G. Pascale, Naples, Italy. 9. Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Abstract
BACKGROUND: The relationship between tumor-infiltrating lymphocytes (TILs) and regression in melanoma is unknown. This report describes a large multicenter study assessing the association between TILs and regression. METHODS: The Sentinel Lymph Node Working Group database was queried from 1993 to 2018 for cases with TILs and regression data. Clinicopathologic factors were correlated with regression and TIL status, sentinel lymph node (SLN) status, and overall survival (OS). RESULTS: The study enrolled 2450 patients. In 1811 cases, TILs (73.9%) were present, with regression present in 328 of these 1811 (18.1%) cases and in 49 (7.7%) of 639 cases without TILs. The presence of TILs was significantly associated with regression (p < 0.0001) as well as a negative SLN (p < 0.05). However, when TILs were stratified by regression status, only absence or presence of both TILs and regression were significantly associated with SLN metastases (p = 0.038). Although the presence of TILs was associated with OS (p < 0.05), regression status by itself was not (p = 0.2058 and 0.252, respectively). Furthermore, when TILs were stratified by regression status, only the presence of TILs with or without regression was significantly associated with improved OS (p = 0.0081 and 0.0137, respectively) versus the absence of both TILs and regression, with regression status not significantly affecting OS for patients with or without TILs (p = 0.2314 and 0.65, respectively). CONCLUSIONS: Regression is highly correlated with TILs, but only TILs are significantly associated with SLN metastasis and OS in melanoma patients, whereas regression is not. The impact of regression on outcomes ultimately appears dependent upon the absence or presence of TILs.
BACKGROUND: The relationship between tumor-infiltrating lymphocytes (TILs) and regression in melanoma is unknown. This report describes a large multicenter study assessing the association between TILs and regression. METHODS: The Sentinel Lymph Node Working Group database was queried from 1993 to 2018 for cases with TILs and regression data. Clinicopathologic factors were correlated with regression and TIL status, sentinel lymph node (SLN) status, and overall survival (OS). RESULTS: The study enrolled 2450 patients. In 1811 cases, TILs (73.9%) were present, with regression present in 328 of these 1811 (18.1%) cases and in 49 (7.7%) of 639 cases without TILs. The presence of TILs was significantly associated with regression (p < 0.0001) as well as a negative SLN (p < 0.05). However, when TILs were stratified by regression status, only absence or presence of both TILs and regression were significantly associated with SLN metastases (p = 0.038). Although the presence of TILs was associated with OS (p < 0.05), regression status by itself was not (p = 0.2058 and 0.252, respectively). Furthermore, when TILs were stratified by regression status, only the presence of TILs with or without regression was significantly associated with improved OS (p = 0.0081 and 0.0137, respectively) versus the absence of both TILs and regression, with regression status not significantly affecting OS for patients with or without TILs (p = 0.2314 and 0.65, respectively). CONCLUSIONS: Regression is highly correlated with TILs, but only TILs are significantly associated with SLN metastasis and OS in melanoma patients, whereas regression is not. The impact of regression on outcomes ultimately appears dependent upon the absence or presence of TILs.
Authors: Nancy E Thomas; Klaus J Busam; Lynn From; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Alison Venn; Peter A Kanetsky; Pamela A Groben; Honglin Hao; Irene Orlow; Anne S Reiner; Li Luo; Susan Paine; David W Ollila; Homer Wilcox; Colin B Begg; Marianne Berwick Journal: J Clin Oncol Date: 2013-10-14 Impact factor: 44.544
Authors: Alison L Burton; Brent A Roach; Michael P Mays; Andrea F Chen; Brooke A R Ginter; Abbey M Vierling; Charles R Scoggins; Robert C G Martin; Arnold J Stromberg; Lee Hagendoorn; Kelly M McMasters Journal: Am Surg Date: 2011-02 Impact factor: 0.688
Authors: W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern Journal: J Natl Cancer Inst Date: 1989-12-20 Impact factor: 13.506
Authors: M Mandalà; G L Imberti; D Piazzalunga; M Belfiglio; R Labianca; M Barberis; L Marchesi; P Poletti; L Bonomi; L Novellino; K Di Biagio; A Milesi; U Guerra; C Tondini Journal: Eur J Cancer Date: 2009-06-22 Impact factor: 9.162
Authors: João Pedreira Duprat; Eduard René Brechtbülh; Bianca Costa de Sá; Mauro Enokihara; Jose Humberto Fregnani; Gilles Landman; Marcus Maia; Felice Riccardi; Francisco Alberto Belfort; Alberto Wainstein; Luciana F Moredo; Higino Steck; Miguel Brandão; Marcelo Moreno; Eduardo Miranda; Ivan Dunshee de Oliveira Santos Journal: PLoS One Date: 2016-02-09 Impact factor: 3.240